Article: Ophthalmic cleared for allergic conjuctivitis

Article: The FDA granted priority review status to Wyeth's NDA.(Pipeline)
Medical Marketing & Media;  March 1, 2005 ;     35 words ...The FDA granted priority review status to Wyeth's NDA for its investigational antibiotic Tygacil (tigecycline) to treat patients with complicated intra-abdominal infections and complicated skin and skin structure infections.

Article: Novartis' Glivec granted priority review status by US FDA.(Clinical report)
Pharma Marketletter;  September 1, 2008 ;     130 words ...Swiss drug major Novartis' Glivec (imatinib) has been granted priority review status by the US Food and Drug Administration as the first therapy to be reviewed for use after surgery in kit-positive gastrointestinal...

Article: Versed gets priority review status
Chain Drug Review;  July 27, 1998 ;     55 words ...The FDA has granted priority review status to the NDA for an orally administered version of Versed, a Hoffmann-LaRoche Inc. drug. The company says the new formulation (an...

Article: The FDA has granted priority review status to Gilead Science's hypertension drug ambrisentan on a priority basis.(PRODUCT NEWS)
Medical Marketing & Media;  April 1, 2007 ;     60 words ...The FDA has granted priority review status to Gilead Science's hypertension drug ambrisentan on a priority basis. Ambrisentan is a potential treatment for pulmonary arterial...

Article: FDA Assigns 'Priority Review' Status To Etanercept sBLA.
Drug Week;  October 19, 2001 ;     432 words ......Food and Drug Administration (FDA) has granted priority review status for Immunex Corp.'s supplemental Biologics...has assigned the ENBREL sBLA a priority review status. Priority review status indicates that the FDA is to act on the...

Article: Vicuron's dalbavacin granted priority review.(Vicuron Pharmaceuticals Inc.'s antibiotic for complicated skin and soft tissue infections)(Brief Article)
Pharma Marketletter;  March 7, 2005 ;     122 words ......news that the US group's New Drug Application for its novel, once-weekly antibiotic dalbavacin has been granted priority review status by the US Food and Drug Administration. The agent is under evaluation for the treatment of complicated...

Article: Fusion inhibitor granted priority review status by FDA.(Brief Article)
AIDS Weekly;  November 11, 2002 ;     431 words ......formerly known as T-20) is fileable and has been granted priority review status. Designed for the treatment of HIV-1 in combination...treatment-experienced patients. The granting of priority review status by the FDA is a critical milestone in bringing...

Article: Fusion inhibitor granted priority review status by FDA.
Biotech Week;  November 13, 2002 ;     431 words ......formerly known as T-20) is fileable and has been granted priority review status. Designed for the treatment of HIV-1 in combination...treatment-experienced patients. The granting of priority review status by the FDA is a critical milestone in bringing...

Article: FDA grants priority review status to 500-mg tablet formulation of Invirase.
Health & Medicine Week;  September 13, 2004 ;     446 words ......13 - (NewsRx.com & NewsRx.net) -- Roche announced that the U.S. Food and Drug Administration (FDA) has granted priority review status to the New Drug Application (NDA) for a 500-mg tablet formulation of its HIV protease inhibitor, Invirase...

Article: Texas Biotechnology's NOVASTAN(R) NDA Granted Priority Review Status by the FDA
PR Newswire;  September 4, 1997 ;     470 words ......today that the Company's recently filed New Drug Application (NDA) for NOVASTAN(R) (argatroban) has been granted priority review status by the U.S. Food and Drug Administration (FDA). On August 6th, Texas Biotechnology and SmithKline Beecham...

Article: STAAR Surgical PMA granted expedited review status by FDA.
Medical Devices & Surgical Technology Week;  August 3, 2003 ;     304 words ......and has been granted an expedited review status. The official filing date for the ICL...Although the granting of expedited review status does not guarantee that the application...consider the granting of expedited review status by the FDA an underscore of this belief...

Article: TOSITUMOMAB.(review status)(Brief Article)
Chemical Market Reporter;  August 30, 1999 ;     38 words ...Coulter Pharmaceutical Inc. and SmithKline Beecham have received priority review status from FDA for Bexxar (tositumomab, iodine I 131 tositumomab). If approved, Bexxar could become the first radioimmunotherapy treatment available commercially.

Article: American Home Products Corporation's Pneumococcal Conjugate Vaccine for Children Receives Priority Review Status from FDA.
PR Newswire;  July 21, 1999 ;     404 words ......Lederle Vaccines unit has gained priority review status from the U.S. Food and Drug Administration...pneumococcal conjugate vaccine. Priority review status means that the FDA has established...time the FDA has assigned priority review status to a vaccine product. The seven-valent...

Article: Novantrone granted priority review.
Chain Drug Review;  August 30, 1999 ;     50 words ...Novantrone, a treatment for multiple sclerosis, has been granted priority review by the FDA. Immunex Corp., which developed the product, is also asking the agency to approve a new label for Enbrel that...